Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 Patients treated with a prospective margin-directed policy

Radiotherapy and Oncology

Volumn 108, Issue 2, 2013, Pages 273-278

  Livi, Lorenzo ^a   Meattini, Icro ^a   Franceschini, Davide ^a   Saieva, Calogero ^b   Meacci, Fiammetta ^a   Marrazzo, Livia ^a   Gerlain, Elena ^b   Desideri, Isacco ^a   Scotti, Vieri ^a   Nori, Jacopo ^a   Sanchez, Luis Jose ^a   Orzalesi, Lorenzo ^a   Bonomo, Pierluigi ^a   Greto, Daniela ^a   Bianchi, Simonetta ^a   Biti, Giampaolo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Molecular and Nutritional Epidemiology Unit Cancer   (Italy)

Author keywords

Breast conserving surgery; Dose escalation; Invasive breast cancer; Radiotherapy boost; Tumor margins

Indexed keywords

ANTHRACYCLINE; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE ESCALATION; TREATMENT OUTCOME;

BREAST-CONSERVING SURGERY; DOSE ESCALATION; INVASIVE BREAST CANCER; RADIOTHERAPY BOOST; TUMOR MARGINS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COHORT STUDIES; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84885377374     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.02.009     Document Type: Article

References (32)

1. B. Fisher, S. Anderson, and J. Bryant Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer N Engl J Med 347 2002 1233 1241
2. A.C. Voogd, M. Nielsen, and J.L. Peterse Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials J Clin Oncol 19 2001 1688 1697
3. M. Clarke, R. Collins, and S. Darby Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials Lancet 366 2005 2087 2106
4. H. Bartelink, J.C. Horiot, P.M. Poortmans, and H. Struikmans Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial J Clin Oncol 25 2007 3259 3265
5. D.E. Wazer, R.K. Schmidt-Ullrich, and C.H. Schmid The value of breast lumpectomy margin assessment as a predictor of residual tumor burden Int J Radiat Oncol Biol Phys 38 1997 291 299
6. C.A. Neuschatz, T. DiPetrillo, and H. Safaii Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast conserving therapy Cancer 97 2003 30 39
7. E. Obedian, and B.G. Haffty Negative margin status improves local control in conservatively managed breast cancer patients Cancer J Sci Am 6 2000 28 33
8. M.C. Smitt, K.W. Nowels, and M.J. Zdeblick The importance of the lumpectomy surgical margin status in long-term results of breast conservation Cancer 76 1995 259 267
9. C.C. Park, M. Mitsumori, and A. Nixon Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence J Clin Oncol 18 2000 1668 1675
10. N. Bouzubar, K.J. Walker, and K. Griffiths Ki67 immunostaining in primary breast cancer: pathological and clinical associations Br J Cancer 59 1989 943 947
11. C.W. Elston, and I.O. Ellis Pathological prognostic factors in breast cancer: I. the value of histological grade in breast cancer - experience from a large study with long-term follow-up Histopathology 41 2002 151 152
12. L.A. Carey, C.M. Perou, and C.A. Livasy Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2006 2492 2502
13. R.C. Millikan, B. Newman, and C.K. Tse Epidemiology of basal-like breast cancer Breast Cancer Res Treat 109 2008 123 139
14. B.D. Smith, D.W. Arthur, and T.A. Buchholz Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO) Int J Radiat Oncol Biol Phys 74 2009 987 1001
15. C. Polgár, E. Van Limbergen, and R. Pötter Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie- European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009) Radiother Oncol 94 2010 264 273
16. L. Cataliotti, V. Distante, and S. Bianchi The importance of resection margins in conservative surgery M.W.E. Morgan, R. Warren, G. Querci della Rovere, Early breast cancer from screening to multidisciplinary management 1998 Harwood Academic Publishers Amsterdam 219 225
17. U. Veronesi, N. Cascinelli, and L. Mariani Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer N Engl J Med 347 2002 1227 1232
18. N. Houssami, P. Macaskill, and M.L. Marinovich Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy Eur J Cancer 46 2010 3219 3232
19. H.A. Jones, N. Antonini, and A.A. Hart Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial J Clin Oncol 27 2009 4939 4947
20. P.M. Poortmans, L. Collette, and H. Bartelink The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial Cancer Radiother 12 2008 565 570
21. P.M. Poortmans, L. Collette, and J.C. Horiot Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial Radiother Oncol 90 2009 80 85
22. C. Polgar, J. Fodor, and T. Major The role of boost irradiation in the conservative treatment of Stage I-II breast cancer Pathol Oncol Res 7 2001 241 250
23. N. Cabioglu, K.K. Hunt, and T.A. Buchholz Improving local control with breast conserving therapy: a 27-year single-institution experience Cancer 104 2005 20 29
24. L. Livi, S. Borghesi, and C. Saieva Benefit of radiation boost after whole-breast radiotherapy Int J Radiat Oncol Biol Phys 75 2009 1029 1034
25. G. Freedman, B. Fowble, and A. Hanlon Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy Int J Radiat Oncol Biol Phys 44 1999 1005 1015
26. H. Bartelink, J.C. Horiot, and P. Poortmans Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation N Engl J Med 345 2001 1378 1387
27. L. Livi, I. Meattini, and C. Saieva The impact of young age on breast cancer outcome Eur J Surg Oncol 36 2010 639 645
28. J. Bergh, P.E. Jönsson, and B. Glimelius Swedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in breast cancer Acta Oncol 40 2001 253 281
29. S. Sioshansi, S. Ehdaivand, and C. Cramer Triple negative breast cancer is associated with an increased risk of residual invasive carcinoma after lumpectomy Cancer 118 2012 3893 3898
30. P. Poortmans, M. Aznar, and H. Bartelink Quality indicators for breast cancer: revisiting historical evidence in the context of technology changes Semin Radiat Oncol 22 2012 29 39
31. M.J. van de Vijver, Y.D. He, and L.J. van't Veer A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 2002 1999 2009
32. Ivaldi GB, Leonardi MC, Orecchia R, et al. Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women. Int J Radiat Oncol Biol Phys 2008;72:485-93.